Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Mallinckrodt
Medtronic
Boehringer Ingelheim

Last Updated: October 6, 2022

TERBUTALINE SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Terbutaline Sulfate patents expire, and when can generic versions of Terbutaline Sulfate launch?

Terbutaline Sulfate is a drug marketed by Akorn, Chartwell Injectable, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, United Biomedcl, Impax Labs, Lannett Co Inc, and Twi Pharms. and is included in nine NDAs.

The generic ingredient in TERBUTALINE SULFATE is terbutaline sulfate. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Drug patent expirations by year for TERBUTALINE SULFATE
Drug Prices for TERBUTALINE SULFATE

See drug prices for TERBUTALINE SULFATE

Recent Clinical Trials for TERBUTALINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kanecia Zimmerman, MD MPHPhase 2/Phase 3
The Emmes Company, LLCPhase 2/Phase 3
Duke HealthPhase 2/Phase 3

See all TERBUTALINE SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for TERBUTALINE SULFATE

US Patents and Regulatory Information for TERBUTALINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078151-001 Jan 7, 2008 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Impax Labs TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 075877-001 Jun 26, 2001 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076887-001 May 26, 2004 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Twi Pharms TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 211832-002 Jun 19, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Impax Labs TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 075877-002 Jun 26, 2001 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chartwell Injectable TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076770-001 Apr 23, 2004 AP RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKesson
Moodys
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.